Entry
Name
Non-alcoholic fatty liver disease - Mus musculus (house mouse)
Description
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum ranging from simple steatosis to more severe steatohepatitis with hepatic inflammation and fibrosis, known as nonalcoholic steatohepatitis (NASH). NASH may further lead to cirrhosis and hepatocellular carcinoma (HCC). This map shows a stage-dependent progression of NAFLD. In the first stage of NAFLD, excess lipid accumulation has been demonstrated. The main cause is the induction of insulin resistance, which leads to a defect in insulin suppression of free fatty acids (FAAs) disposal. In addition, two transcription factors, SREBP-1c and PPAR-alpha, activate key enzymes of lipogenesis and increase the synthesis of FAAs in liver. In the second stage, as a consequence of the progression to NASH, the production of reactive oxygen species (ROS) is enhanced due to oxidation stress through mitochondrial beta-oxidation of fatty acids and endoplamic reticulum (ER) stress, leading to lipid peroxidation. The lipid peroxidation can further cause the production of cytokines (Fas ligand, TNF-alpha, IL-8 and TGF), promoting cell death, inflammation and fibrosis. The activation of JNK, which is induced by ER stress, TNF-alpha and FAAs, is also associated with NAFLD progression. Increased JNK promotes cytokine production and initiation of HCC.
Class
Human Diseases; Endocrine and metabolic disease
BRITE hierarchy
Pathway map
mmu04932 Non-alcoholic fatty liver disease
Ortholog table
Organism
Mus musculus (house mouse) [GN:
mmu ]
Gene
12702 Socs3; suppressor of cytokine signaling 3 [KO:K04696 ]
21937 Tnfrsf1a; tumor necrosis factor receptor superfamily, member 1a [KO:K03158 ]
18033 Nfkb1; nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 [KO:K02580 ]
19697 Rela; v-rel reticuloendotheliosis viral oncogene homolog A (avian) [KO:K04735 ]
18706 Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922 ] [EC:2.7.1.153 ]
18707 Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922 ] [EC:2.7.1.153 ]
74769 Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922 ] [EC:2.7.1.153 ]
18709 Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649 ]
18708 Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649 ]
18710 Pik3r3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649 ]
22259 Nr1h3; nuclear receptor subfamily 1, group H, member 3 [KO:K08536 ]
20787 Srebf1; sterol regulatory element binding transcription factor 1 [KO:K07197 ]
11450 Adipoq; adiponectin, C1Q and collagen domain containing [KO:K07296 ]
19079 Prkab1; protein kinase, AMP-activated, beta 1 non-catalytic subunit [KO:K07199 ]
108097 Prkab2; protein kinase, AMP-activated, beta 2 non-catalytic subunit [KO:K07199 ]
19082 Prkag1; protein kinase, AMP-activated, gamma 1 non-catalytic subunit [KO:K07200 ]
241113 Prkag3; protein kinase, AMP-activated, gamma 3 non-catalytic subunit [KO:K07200 ]
108099 Prkag2; protein kinase, AMP-activated, gamma 2 non-catalytic subunit [KO:K07200 ]
19013 Ppara; peroxisome proliferator activated receptor alpha [KO:K07294 ]
19016 Pparg; peroxisome proliferator activated receptor gamma [KO:K08530 ]
12606 Cebpa; CCAAT/enhancer binding protein alpha [KO:K09055 ]
13106 Cyp2e1; cytochrome P450, family 2, subfamily e, polypeptide 1 [KO:K07415 ] [EC:1.14.14.-]
21803 Tgfb1; transforming growth factor, beta 1 [KO:K13375 ]
13666 Eif2ak3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860 ] [EC:2.7.11.1 ]
13665 Eif2s1; eukaryotic translation initiation factor 2, subunit 1 alpha [KO:K03237 ]
11911 Atf4; activating transcription factor 4 [KO:K04374 ]
13198 Ddit3; DNA-damage inducible transcript 3 [KO:K04452 ]
12122 Bid; BH3 interacting domain death agonist [KO:K04726 ]
78330 Ndufv3; NADH:ubiquinone oxidoreductase core subunit V3 [KO:K03944 ]
54405 Ndufa1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945 ]
17991 Ndufa2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946 ]
66091 Ndufa3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947 ]
17992 Ndufa4; Ndufa4, mitochondrial complex associated [KO:K03948 ]
407790 Ndufa4l2; Ndufa4, mitochondrial complex associated like 2 [KO:K03948 ]
68202 Ndufa5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949 ]
67130 Ndufa6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950 ]
66416 Ndufa7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951 ]
68375 Ndufa8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952 ]
66108 Ndufa9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953 ]
67273 Ndufa10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954 ]
70316 Ndufab1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955 ]
102634451 Ndufab1-ps; NADH:ubiquinone oxidoreductase subunit AB1b [KO:K03955 ]
69875 Ndufa11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956 ]
66414 Ndufa12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352 ]
67184 Ndufa13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353 ]
68198 Ndufb2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958 ]
66495 Ndufb3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959 ]
68194 Ndufb4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960 ]
66046 Ndufb5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961 ]
230075 Ndufb6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962 ]
66916 Ndufb7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963 ]
67264 Ndufb8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964 ]
66218 Ndufb9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965 ]
68342 Ndufb10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966 ]
104130 Ndufb11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351 ]
17993 Ndufs4; NADH:ubiquinone oxidoreductase core subunit S4 [KO:K03937 ]
595136 Ndufs5; NADH:ubiquinone oxidoreductase core subunit S5 [KO:K03938 ]
407785 Ndufs6; NADH:ubiquinone oxidoreductase core subunit S6 [KO:K03939 ]
623286 Ndufs6b; NADH:ubiquinone oxidoreductase subunit S6B [KO:K03939 ]
66377 Ndufc1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967 ]
68197 Ndufc2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968 ]
66945 Sdha; succinate dehydrogenase complex, subunit A, flavoprotein (Fp) [KO:K00234 ] [EC:1.3.5.1 ]
67680 Sdhb; succinate dehydrogenase complex, subunit B, iron sulfur (Ip) [KO:K00235 ] [EC:1.3.5.1 ]
66052 Sdhc; succinate dehydrogenase complex, subunit C, integral membrane protein [KO:K00236 ]
66925 Sdhd; succinate dehydrogenase complex, subunit D, integral membrane protein [KO:K00237 ]
66694 Uqcrfs1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411 ] [EC:7.1.1.8 ]
22273 Uqcrc1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414 ]
67003 Uqcrc2; ubiquinol cytochrome c reductase core protein 2 [KO:K00415 ]
66576 Uqcrh; ubiquinol-cytochrome c reductase hinge protein [KO:K00416 ]
67530 Uqcrb; ubiquinol-cytochrome c reductase binding protein [KO:K00417 ]
22272 Uqcrq; ubiquinol-cytochrome c reductase, complex III subunit VII [KO:K00418 ]
66152 Uqcr10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419 ]
66594 Uqcr11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420 ]
17710 COX3; cytochrome c oxidase subunit III [KO:K02262 ]
17709 COX2; cytochrome c oxidase subunit II [KO:K02261 ]
12857 Cox4i1; cytochrome c oxidase subunit 4I1 [KO:K02263 ]
84682 Cox4i2; cytochrome c oxidase subunit 4I2 [KO:K02263 ]
12858 Cox5a; cytochrome c oxidase subunit 5A [KO:K02264 ]
12859 Cox5b; cytochrome c oxidase subunit 5B [KO:K02265 ]
12861 Cox6a1; cytochrome c oxidase subunit 6A1 [KO:K02266 ]
12862 Cox6a2; cytochrome c oxidase subunit 6A2 [KO:K02266 ]
110323 Cox6b1; cytochrome c oxidase, subunit 6B1 [KO:K02267 ]
12864 Cox6c; cytochrome c oxidase subunit 6C [KO:K02268 ]
12866 Cox7a2; cytochrome c oxidase subunit 7A2 [KO:K02270 ]
12865 Cox7a1; cytochrome c oxidase subunit 7A1 [KO:K02270 ]
20463 Cox7a2l; cytochrome c oxidase subunit 7A2 like [KO:K02270 ]
66142 Cox7b; cytochrome c oxidase subunit 7B [KO:K02271 ]
78174 Cox7b2; cytochrome c oxidase subunit 7B2 [KO:K02271 ]
12867 Cox7c; cytochrome c oxidase subunit 7C [KO:K02272 ]
12868 Cox8a; cytochrome c oxidase subunit 8A [KO:K02273 ]
12869 Cox8b; cytochrome c oxidase subunit 8B [KO:K02273 ]
75483 Cox8c; cytochrome c oxidase subunit 8C [KO:K02273 ]
Compound
Reference
Authors
Naik A, Kosir R, Rozman D
Title
Genomic aspects of NAFLD pathogenesis.
Journal
Reference
Authors
Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L
Title
Molecular mechanisms involved in NAFLD progression.
Journal
Reference
Authors
Seki E, Brenner DA, Karin M
Title
A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.
Journal
Reference
Authors
Tilg H, Moschen AR
Title
Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.
Journal
Reference
Authors
Larter CZ, Farrell GC
Title
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
Journal
Reference
Authors
Farrell GC, van Rooyen D, Gan L, Chitturi S
Title
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.
Journal
Reference
Authors
Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P
Title
The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease.
Journal
Reference
Authors
Hotamisligil GS
Title
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.
Journal
Reference
Authors
Parekh S, Anania FA
Title
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Journal
Reference
Authors
Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ
Title
JNK1 but not JNK2 promotes the development of steatohepatitis in mice.
Journal
Reference
Authors
Leung TM, Nieto N
Title
CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
Journal
Reference
Authors
Zafrani ES
Title
Non-alcoholic fatty liver disease: an emerging pathological spectrum.
Journal
Reference
Authors
Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ
Title
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.
Journal
Reference
Authors
Begriche K, Igoudjil A, Pessayre D, Fromenty B
Title
Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.
Journal
Reference
Authors
Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, Dargel R, Poli G
Title
The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis.
Journal
Reference
Authors
Malhi H, Kaufman RJ
Title
Endoplasmic reticulum stress in liver disease.
Journal
Reference
Authors
Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM
Title
Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.
Journal
Reference
Authors
Serviddio G, Sastre J, Bellanti F, Vina J, Vendemiale G, Altomare E
Title
Mitochondrial involvement in non-alcoholic steatohepatitis.
Journal
Reference
Authors
Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B
Title
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
Journal
Related pathway
mmu04141 Protein processing in endoplasmic reticulum
mmu04920 Adipocytokine signaling pathway
KO pathway
LinkDB
All DBs